Compare CDRO & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDRO | MXCT |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.5M | 186.7M |
| IPO Year | N/A | 2021 |
| Metric | CDRO | MXCT |
|---|---|---|
| Price | $7.62 | $1.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $9.00 | $7.50 |
| AVG Volume (30 Days) | 52.5K | ★ 1.6M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $207,789,626.00 | $34,419,000.00 |
| Revenue This Year | $10.04 | N/A |
| Revenue Next Year | $9.24 | $10.69 |
| P/E Ratio | $92.97 | ★ N/A |
| Revenue Growth | ★ 24.16 | N/A |
| 52 Week Low | $5.18 | $1.26 |
| 52 Week High | $8.75 | $5.20 |
| Indicator | CDRO | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 70.91 | 44.35 |
| Support Level | $6.78 | $1.50 |
| Resistance Level | $7.39 | $1.65 |
| Average True Range (ATR) | 0.36 | 0.11 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 81.05 | 22.37 |
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.